← Back to Patent Explorer
US4906477A Expired / Lapsed US ⏱️ 0.0 years remaining

Antineoplastic agent-entrapping liposomes

Assignee: VITAMIN KENKYUSYO KK
•
Filing: 1988-02-08
•
Granted: 1990-03-06
•
Expires: 2008-02-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Some of antineoplastic agents, for instance, adriamycin and daunorubicin, have a positive charge at physiological pH. Such drugs possess high affinity for binding to steroidal sulfate by means of electrostatic force. The invention utilizes this property to prepare steroidal sulfate liposomes having a net negative charge and encapsulating the antineoplastic agent.

Inventors

  • 👤 Masayasu Kurono
  • 👤 Hitoshi Noda
  • 👤 Tomio Ogasawara
  • 👤 Hidefumi Yamakawa
  • 👤 Takafumi Iida
  • 👤 Kunio Yagi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 05:22
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/10; A61K9/127; A61K9/1271; A61K9/1272; A61P; A61P35/00; Y; Y10; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 29 words
An antineoplastic composition comprising a liposome, the lipids constituting the liposome consisting essentially of phosphatidylcholine, cholesterol and a steroidal sulfate ester; and an antineoplastic agent entrapped in the liposome.
Claim 2
Dependent Claim 29 words
An antineoplastic composition comprising a liposome, the lipids constituting the liposome consisting essentially of phosphatidylcholine, cholesterol and a steroidal sulfate ester; and an antineoplastic agent entrapped in the liposome.
Claim 3
Dependent Claim 14 words
A composition according to claim 1, wherein the steroid sulfate ester is cholesterol sulfate.
Claim 4
Dependent Claim 12 words
A composition according to claim 1, wherein the antineoplastic agent is adriamycin.
Claim 5
Dependent Claim 12 words
A composition according to claim 2, wherein the antineoplastic agent is adriamycin.

References Cited (Backward Citations)

US4746516A Cited
US4544545A Cited
US4605630A Cited
US4745074A Cited
US4780455A Cited
US4766046A Cited
US4756910A Cited
US4822777A Cited
US4828837A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-03-05 1993-09-04 1994-03-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-03-05 1997-09-04 1998-03-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-03-05 2001-09-04 2002-03-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag